52. Blake, P. A., Feldman, R. A., and Buchanan, T. M. Serologic therapy of tetanus in the United States, 1965—1971. J.A.M.A. 235:42, 1976.
53. Bleck, T. P. Tetanus: Pathophysiology, management, and prophylaxis. D. M. 37(9):545, 1991.
54. Dowell, V. R., Jr. Botulism and tetanus: Selected epidemiologic and microbiologic aspects. Rev. Infect. Dis. (Suppl. 1):S202, 1984.
55. Hambleton, P. Clostridium botulinum toxins: A general review of involvement in disease, structure, mode of action and preparation for clinical use. J. Neurol. 239(1):16, 1992.
56. Richardson, J. P. and Knight, A. L. The prevention of tetanus in the elderly. Arch. Intern. Med. 151(9):1712, 1991.
57. Schreiner, M. S., Field, E., and Ruddy, R. Infant botulism: A review of 12 years' experience at the Children's Hospital of Philadelphia. Pediatrics 87(2):159, 1991.
58. Sutton, D. N., et al. Management of autonomic dysfunction in severe tetanus: The use of magnesium sulphate and clonidine. Intens. Care Med. 16(2):75, 1990.